Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;2(1):137-9.
doi: 10.1001/jamaoncol.2015.3924.

Patient Income Level and Cancer Clinical Trial Participation: A Prospective Survey Study

Affiliations

Patient Income Level and Cancer Clinical Trial Participation: A Prospective Survey Study

Joseph M Unger et al. JAMA Oncol. 2016 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest disclosures: The authors have no disclosures.

Figures

Figure 1
Figure 1
Forest plot of the association of income and clinical trial participation by each factor included in the multivariable regression model. Each square represents an odds ratio (OR), and each horizontal line is the 95% CI. The vertical line is the line of equal odds. For lower-income individuals, the odds of clinical trial participation were consistently lower (that is, to the left of the line of equal odds) within nearly all subgroups of all the factors included in this analysis. Only some of these findings are statistically significant, likely due to limited power. There was no statistical evidence that the association of income and clinical trial participation differed according to any of the covariates (interaction p>.15 in all cases).

Similar articles

Cited by

References

    1. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004 Jun 9;291(22):2720–6. - PubMed
    1. Unger JM, Hershman DL, Albain KS, et al. Patient income level and cancer clinical trial participation. J Clin Oncol. 2013 Feb 10;31(5):536–42. doi: 10.1200/JCO.2012.45.4553. Epub 2013 Jan 7. - DOI - PMC - PubMed
    1. Javid SH, Unger JM, Gralow JR, et al. A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316) Oncologist. 2012;17(9):1180–90. Epub 2012 Jun 20. - PMC - PubMed
    1. Unger JM, Coltman CA, Jr, Crowley JJ, et al. Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. J Clin Oncol. 2006 Jan 1;24(1):141–4. Epub 2005 Dec 5. - PubMed
    1. Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013;18(4):381–90. doi: 10.1634/theoncologist.2012-0279. Epub 2013 Feb 26. - DOI - PMC - PubMed

Publication types